POLIOMYELITIS VACCINE (ORAL), BIVALENT TYPES 1 AND 3. TYPE - I ?106.0 CCID50 TYPE - III ?105.8 CCID50 ORAL LIQUID ORDINAR Уганда - англійська - National Drug Authority

poliomyelitis vaccine (oral), bivalent types 1 and 3. type - i ?106.0 ccid50 type - iii ?105.8 ccid50 oral liquid ordinar

serum institute of india pvt ltd - polio virus (sabin) - oral liquid ordinary liquids - type - i ?106.0 ccid50 type - iii ?105.8 ccid50

Poliorix inj. sol. i.m. vial Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

poliorix inj. sol. i.m. vial

glaxosmithkline biologicals sa-nv - poliomyelitis virus, inactivated - solution for injection - poliomyelitis virus - poliomyelitis, trivalent, inactivated, whole virus

INFANRIX HEXA Ізраїль - англійська - Ministry of Health

infanrix hexa

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus b; hepatitis b vaccines; pertactin; pertussis toxoid (pt); poliovirus type 1 inactivated; poliovirus type 2 inactivated; poliovirus type 3 inactivated; tetanus toxoid - powder and suspension for suspension for injection - filamentous haemagglutinin (fha) 25 mcg/dose; diphtheria toxoid nlt 30 iu/dose; tetanus toxoid nlt 40 iu/dose; hepatitis b vaccines 10 mcg/dose; poliovirus type 1 inactivated 40 du/dose; poliovirus type 2 inactivated 8 du/dose; poliovirus type 3 inactivated 32 du/dose; haemophilus b 10 mcg/dose; pertactin 8 mcg/dose; pertussis toxoid (pt) 25 mcg/dose - bacterial and viral vaccines, combined - infantix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and disease caused by haemophilus influenza type b for infants between 6 weeks and 36 months of age.

Polio Sabin Mono One or. susp. vial Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

polio sabin mono one or. susp. vial

glaxosmithkline biologicals sa-nv - poliovirus type 1 (live, attenuated) - oral suspension - poliomyelitis virus - poliomyelitis oral, monovalent, live attenuated

Polio Sabin Mono Three (Oral) or. susp. vial Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

polio sabin mono three (oral) or. susp. vial

glaxosmithkline biologicals sa-nv - poliovirus type 3 (live, attenuated) - oral suspension - poliomyelitis virus - poliomyelitis oral, monovalent, live attenuated

Polio Sabin Trivalent (10-1-3) or. susp. Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

polio sabin trivalent (10-1-3) or. susp.

glaxosmithkline biologicals sa-nv - poliovirus type 1 (live, attenuated) ; poliovirus type 2 (live, attenuated) ; poliovirus type 3 (live, attenuated) - oral suspension - poliomyelitis virus - poliomyelitis oral, trivalent, live attenuated

Polio Sabin Trivalent (10-1-6) or. susp. Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

polio sabin trivalent (10-1-6) or. susp.

glaxosmithkline biologicals sa-nv - poliovirus type 2 (live, attenuated) ; poliovirus type 3 (live, attenuated) ; poliovirus type 1 (live, attenuated) - oral suspension - poliomyelitis virus - poliomyelitis oral, trivalent, live attenuated

POLIORIX INACTIVATED POLIO VACCINE Нігерія - англійська - NAFDAC (National Agency for Food and Drugs Administration and Control)

poliorix inactivated polio vaccine

inactivated polio virus type 1,2 &3

Hexyon Європейський Союз - англійська - EMA (European Medicines Agency)

hexyon

sanofi pasteur europe - filamentous haemagglutinin, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate), hepatitis b surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (mahoney strain) produced on vero cells, poliovirus (inactivated) type 2 (mef-1 strain) produced on vero cells, poliovirus (inactivated) type 3 (saukett strain) produced on vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, diphtheria toxoid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines - hexyon (dtap-ipv-hb-hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib).the use of this vaccine should be in accordance with official recommendations.

Hexacima Європейський Союз - англійська - EMA (European Medicines Agency)

hexacima

sanofi pasteur - hepatitis b surface antigen, diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens pertussis toxoid filamentous haemagglutinin, poliovirus (inactivated) type 1 (mahoney) type 2 (mef-1) type 3 (saukett), haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines, bacterial and viral vaccines, combined - hexacima (dtap-ipv-hb-hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib).the use of this vaccine should be in accordance with official recommendations.